Table 3

Hyperglycemia in patients with diabetes by surgical service for patients who had at least one capillary glucose measurement (POCT)

Surgical typeTotal cohortPatients with diabetes
TotalAt least one POCT measurementAny hyperglycemiaModerate hyperglycemiaSevere hyperglycemia
All patients65761165965 (82.8)633 (65.7)140 (16.9)47 (5.1)
Gastrointestinal1 (0.0)0
General surgery1336 (20.3)240 (20.6)198 (82.5)142 (59.2)34 (14.2)12 (5.0)
Gynecology930 (14.1)141 (12.1)122 (86.5)87 (61.7)18 (12.8)3 (2.1)
Neurosurgery625 (9.5)84 (7.2)73 (86.9)39 (46.4)12 (14.3)2 (2.4)
Ophthalmology2 (0.0)0
Oral maxillofacial1 (0.0)0
Orthopedic surgery1427 (21.7)263 (22.6)215 (81.1)134 (50.6)21 (7.9)11 (4.2)
Otolaryngology179 (2.7)33 (2.8)17 (51.5)12 (36.4)3 (9.1)1 (3.3)
Plastic surgery186 (2.8)32 (2.8)30 (90.9)19 (57.6)4 (12.1)2 (6.1)
Radiology4 (0.1)0
Spine surgery856 (13.0)138 (11.9)117 (84.5)68 (28.6)14 (10.1)2 (1.4)
Thoracic surgery370 (5.6)50 (4.3)40 (80.0)32 (64.0)7 (14.0)2 (4.0)
Transplant126 (1.9)52 (4.5)48 (92.3)40 (76.9)15 (28.8)10 (19.2)
Urology21 (0.3)4 (0.3)1 (25.0)1 (25.0)00
Vascular512 (7.8)128 (11.0)104 (81.3)59 (46.1)12 (42.9)2 (1.6)
  • Capillary glucose between 4.0 and 10.0 mmol/L is considered within target; moderate hyperglycemia is 14.0–17.9 mmol/L; severe hyperglycemia is ≥18.0 mmol/L.

  • POCT, point-of-care testing.